Local Bounti Corporation/DE (LOCL): Nasdaq/NYSE listing notice — Local Bounti receives NYSE delisting notice for sub-$1.00 stock price

Local Bounti Corporation/DE

NYSE notified Local Bounti on Feb 28, 2023 that average closing price was below $1.00 over 30 consecutive trading days.
Company has six months from notice to regain compliance; no immediate delisting effect.
Local Bounti may pursue a reverse stock split, subject to stockholder approval, to cure deficiency.
Common stock (LOCL) and warrants (LOCL WS) continue trading on NYSE during cure period.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Local Bounti Corporation/DE received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

February 28, 2023, Local Bounti Corporation (the “ Company ”) received written notice from the New York Stock Exchange (the “ NYSE ”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice has no immediate effect on the listing of the Company’s common stock, which will continue to be listed and traded on the NYSE, subject to the Company’s compliance with other NYSE continued listing standards. In accordance with the NYSE Listed Co

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Local Bounti Corporation/DE filing history →

Source: SEC EDGAR

accession 0001840780-23-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.